The legacy business model in consumer and retail is the pipe through which value is generated upstream and delivered to consumers downstream. As everyone is aware, a powerful alternative has emerged. Today “platform” enterprises such as Alibaba, Amazon, Tencent and Uber are dominant business titans.
It is seldom that a trend benefits all key players in a given market, but the proliferation of self-care and the growth of the over-the-counter medication market is one of those trends. Drug retailers, consumers and the U.S.
Today’s product landscape is highly competitive. Speed-to-market continues to be an important product launch factor, but it isn’t everything. Often, overly eager companies introduce a new CPG item too quickly while overlooking critical steps that could prevent costly mistakes.
and is forecast to reach $63.5 billion by 2024, a
a bold departure for a pharmacy chain in this country, one that sadly has yet to be matched by any of the company’s peers — was intended to discourage smokers from indulging in a habit that is clearly
The news out of Rhode Island that Judy Sansone, chief merchant at CVS Pharmacy, will shortly retire signals more than the end of a remarkable and productive retail career.
In a recent column, Chain Drug Review editor David Pinto described the 2019 NACDS Annual Meeting this way: “In an ever-changing retail universe, a world where today’s bright hope is tomorrow’s used-to-be, the [NACDS] Annual Meeting, held each spring, remains the standard by which retail meetings are
the use of marijuana in plant form or its basic extracts. Although some states have legalized its use, the Food and Drug Administration has not approved marijuana in plant
The last three years have been very tough for retail pharmacies.
As specialty drugs grow in importance and prominence, this is an ideal moment to consider the essential and evolving roles retail pharmacies play in this significant health care category.
The continued digitization of electronic health records (EHRs) and growth in the number of wearables and Internet of Things (IoT) devices are rapidly expanding the volume of patient data.
Now is the time for Food and Drug Administration reforms designed to dramatically increase the number of prescription-to-O-T-C switches in the U.S.
Perhaps the best way to begin the complicated story of generic drugs, and how using a data-based approach could help pharmacists, is to tell a bit about the rise of generics.
In Dr. Seuss’ (Theodor Geisel’s) last major book, Oh, the Places You’ll Go!, he put forth advice for recent graduates from almost any school: You have brains in your head. You have feet in your shoes. You can steer yourself. Any direction you choose. And you’re on your own.
In 2018, five national pharmacy associations and a growing number of state associations launched Pharmacists for Healthier Lives, (PfHL), a public education campaign targeting influential groups of consumers and health professionals.
legal proceedings in which it is asserted that retailers and drug wholesalers bear at least some responsibility for the ongoing opioid epidemic; the emergence of
